Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir (RALBAT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by University of Turin, Italy
University of Turin, Italy
University of Milan
Information provided by (Responsible Party):
Giovanni Di Perri, University of Turin, Italy Identifier:
First received: July 10, 2013
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)